Join us for a 1.5-day public workshop that will examine the major advancements in scientific, technological, and social innovations that have been taking place to tackle microbial threats, including diagnostics, vaccine development and production, new antimicrobials as well as non-pharmaceutical interventions and surveillance.

Join NASEM in the release of the new report: Regulating Medicines in a Globalized World: Need for Increased Reliance Among Regulators

A planning committee will plan and conduct a 1.5-day public workshop to explore how health professions education and practice organizations and programs, are currently addressing social determinants that contribute to mental health disparities across the lifespan. The workshop will also set the stage for discussions on how disparities can affect the mental health and well-being of patients, families, communities, and care providers across the learning continuum. The planning committee will develop a workshop agenda, select and invite speakers and discussants, and moderate the discussions. Following the workshop, a proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.

This workshop will bring together an international, interdisciplinary group of experts to explore what is known, and what critical knowledge gaps remain, regarding existing and possible future risks of harmful infectious agents emerging from thawing Arctic environments

This workshop will track how a PPP establishes itself from the country/municipal level down to the local level.

Meeting 4: Mutual Recognition Agreements in the Regulation of Medicines

The Committee on Mutual Recognition Agreements and Reliance in the Regulation of Medicines will meet on Friday, August 2nd, 2019​ in-person and through virtual conference.

The Committee on Mutual Recognition Agreements and Reliance in the Regulation of Medicines will meet on Wednesday, July 24th, 2019 through virtual conference.

Mutual Recognition Agreements and Reliance in the Regulation of Medicines Information Gathering Session 13

Meeting 3: Mutual Recognition Agreements in the Regulation of Medicines